Skip to content

Ardelyx ARDX Debt-to-equity

Debt-to-equity at other companies

Amgen logo
AmgenAMGN
6.2×-3.0×
AbbVie logo
AbbVieABBV
46.6×+38.6×
XER
Xeris Biopharma Holdings, Inc.XERS
19.9×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×-0.1×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
0.2×-0.1×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
0.0×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's debt-to-equity?
Ardelyx (ARDX) reported debt-to-equity of 1.4× in Q1 2026.
How has Ardelyx's debt-to-equity changed year-over-year?
Ardelyx's debt-to-equity increased by 31.6% year-over-year, from 1.1× to 1.4×.
What is the long-term trend for Ardelyx's debt-to-equity?
Over 5 years (2020 to 2025), Ardelyx's debt-to-equity has grown at a 128.3% compound annual growth rate (CAGR), from 0× to 1.2×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.